You've probably answered your own question - they want to be free to raise more capital if an investor comes along. This is normal. In my experience, assurances from a biotech that it has enough money to complete its trials aren't worth the paper they're written on.
ACW Price at posting:
3.3¢ Sentiment: Hold Disclosure: Held
